A., & Mbah, J
These results were so impressive that tirzepatide earned its own place in weight management: as of late 2023, the FDA has also approved it under the name Zepbound specifically for chronic weight management in obesity (making it officially indicated for weight loss, not just diabetes)
The analysis extends beyond identifying which physicians prescribed which medications to reveal the intent and context that shape prescribing behaviors
This can be due to either an increase in the rate of protein oxidation or a decrease in the rate of oxidized protein repair, or a combination of both
48 ), were obtained from Twist Bioscience in a pTwist Amp backbone (Supplementary Table 2)
Carpenter, B., Nehm, R., Warne, T., Leslie, A